FDA's Budget Flat In House Bill, But Path For 'Cures' Funding Cleared

US agency's budget authority would remain at current level under FY 2018 appropriations bill reported out by a House subcommittee; measure includes language enabling FDA's Oncology Center of Excellence to receive 21st Century Cures funding transferred from National institutes of Health.

Capitol House

A US House subcommittee adopted a fiscal year 2018 funding measure that would maintain FDA’s non-user fee appropriations at the current level while also clearing the way for the agency to receive from the National Institutes of Health funds authorized under the 21st Century Cures Act.

On June 28, the House Appropriations Committee’s agriculture subcommittee unanimously voted to send to the full committee a measure that...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Legislation

More from Pink Sheet